Bao et al. found that LysoPC (17:0) reduced blood glucose and alleviated insulin resistance and related metabolic disorders in HF diet-induced mice by activating glucagon-like peptide 1 and promoting insulin secretion [56]. This evidence concerns the gene GCG and metabolic disease.